25 May 2013
Keywords: medimmune, sanofi, pasteur, ip, licensing, accord, usa-based
Article | 09 April 2007
USA-based MedImmune says that it has licensed its proprietary reverse genetics intellectual property to Sanofi Pasteur, the vaccines division
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 April 2007
16 April 2007
24 May 2013
© 2013 thepharmaletter.com